For research use only. Not for therapeutic Use.
Enisamium Iodide(CAT: I006672) is an antiviral and anti-inflammatory agent primarily used in the treatment of respiratory infections, including influenza. It is believed to work by inhibiting viral RNA polymerase, disrupting viral replication, and modulating the host immune response to reduce inflammation. Enisamium Iodide has shown promise in research aimed at treating viral infections by reducing both the severity and duration of symptoms. Its broad-spectrum antiviral properties make it a compound of interest in studies focused on developing new therapeutic options for viral respiratory diseases, especially in light of emerging viral threats and drug resistance concerns.
Catalog Number | I006672 |
CAS Number | 201349-37-3 |
Synonyms | Enisamium iodide, brand name: Amizon.;4-(benzylcarbamoyl)-1-methylpyridin-1-ium iodide |
Molecular Formula | C14H15IN2O |
Purity | ≥95% |
Solubility | Soluble in DMSO, not in water |
Storage | 0 - 4°C for short term or -20 °C for long term |
IUPAC Name | N-benzyl-1-methylpyridin-1-ium-4-carboxamide;iodide |
InChI | InChI=1S/C14H14N2O.HI/c1-16-9-7-13(8-10-16)14(17)15-11-12-5-3-2-4-6-12;/h2-10H,11H2,1H3;1H |
InChIKey | ILSOAHPXYZRFBA-UHFFFAOYSA-N |
SMILES | C[N+]1=CC=C(C=C1)C(=O)NCC2=CC=CC=C2.[I-] |